The impact of biofilm-producing bacteria on chronic bacterial prostatitis treatment: Results from a longitudinal cohort study

World Journal of Urology

Volumn 32, Issue 3, 2014, Pages 737-742

  Bartoletti, Riccardo ^a   Cai, Tommaso ^b   Nesi, Gabriella ^a   Albanese, Sara ^c   Meacci, Francesca ^c   Mazzoli, Sandra ^c   Naber, Kurt ^d  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Hospital Santa Chiara of Trento   (Italy)

^c SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Bacterial biofilm; Bacterial prostatitis; CP CPPS; Prostate calcifications; Prostatitis

Indexed keywords

ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; BACTERIA; BIOFILM; CHRONIC DISEASE; COMPARATIVE STUDY; FOLLOW UP; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; MALE; METABOLISM; MICROBIOLOGY; PROGNOSIS; PROSTATITIS; RETROSPECTIVE STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BACTERIA; BIOFILMS; CHRONIC DISEASE; FOLLOW-UP STUDIES; HUMANS; MALE; PROGNOSIS; PROSTATITIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84901501247     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-013-1145-9     Document Type: Article

References (27)

1. Bartoletti R, Cai T, Mondaini N et al (2007) Prevalence, incidence estimation, risk factors and characterization of chronic prostatitis/chronic pelvic pain syndrome in urological hospital outpatients in Italy: results of a multi center case-control observational study. J Urol 178(6): 2411-2415.
2. Krieger JN, Nyberg L Jr, Nickel JC (1999) NIH consensus definition and classification of prostatitis. JAMA 282(3): 236-237.
3. Drach GW, Fair WR, Meares EM, Stamey TA (1978) Classification of benign diseases associated with prostatic pain: prostatitis or prostatodynia? J Urol 120(2): 266.
4. Grabe M, Bjerklund-Johansen TE, Botto H et al (2012) Guidelines on urological infections. In: Grabe M, Bjerklund-Johansen TE, Botto H, Wullt B, Çek M, Naber KG, Pickard RS, Tenke P, Wagenlehner F (eds) European Association of Urology Guidelines, ch 10. 4. 1, p 69.
5. Wagenlehner FM, Naber KG (2003) Antimicrobial treatment of prostatitis. Expert Rev Anti Infect Ther 1(2): 275-282.
6. Fulmer BR, Turner TT (2000) A blood-prostate barrier restricts cell and molecular movement across the rat ventral prostate epithelium. J Urol 163(5): 1591-1594.
7. Bartoletti R, Cai T (2009) Chronic prostatitis and biofilm. Infez Med 17(1): 10-16.
8. Kanamaru S, Kurazono H, Terai A, Monden K, Kumon H, Mizunoe Y, Ogawa O, Yamamoto S (2006) Increased biofilm formation in Escherichia coli isolated from acute prostatitis. Int J Antimicrob Agents 28(1): S21-S25.
9. Mazzoli S (2010) Biofilms in chronic bacterial prostatitis (NIH-II) and in prostatic calcifications. FEMS Immunol Med Microbiol 59(3): 337-344.
10. Porta M (ed) (2008) A dictionary of epidemiology, 5th edn. Oxford University Press, New York.
11. Giubilei G, Mondaini N, Crisci A et al (2005) The Italian version of the National Institutes of Health Chronic Prostatitis Symptom Index. Eur Urol 47(6): 805-811.
12. Badia X, Garcia-Losa M, Dal-Re R (1997) Ten-language translation and harmonization of the International Prostate Symtom Score: developing a methodology for multinational clinical trials. Eur Urol 31(2): 129-140.
13. Christensen GD, Simpson WA, Younger JJ et al (1985) Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol 22(6): 996-1006.
14. Rubin RH, Shapiro ED, Andriole VT, Davis RJ, Stamm WE (1992) Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 15(1): S216-S227.
15. Trinchieri A (2001) Role of levofloxacin in the treatment of urinary tract infections. Arch Ital Urol Androl 73(2): 105-113.
16. Litwin MS, McNaughton-Collins M, Fowler FJ, Nickel JC, Calhoun EA, Pontari MA et al (1999) The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. J Urol 162: 369.
17. Mazzoli S, Cai T, Rupealta V et al (2007) Interleukin 8 and anti-chlamydia trachomatis mucosal IgA as urogenital immunologic markers in patients with C. trachomatis prostatic infection. Eur Urol 51(5): 1385-1393.
18. Cai T, Wagenlehner FM, Mazzoli S et al (2012) Semen quality in patients with Chlamydia trachomatis genital infection treated concurrently with prulifloxacin and a phytotherapeutic agent. J Androl 33(4): 615-623.
19. Nickel JC, Alexander RB, Schaeffer AJ, Landis JR, Knauss JS, Propert KJ (2003) Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls. J Urol 170: 818-822.
20. Soto SM, Smithson A, Martinez JA et al (2007) Biofilm formation in uropathogenic Escherichia coli strains: relationship with prostatitis, urovirulence factors and antimicrobial resistance. J Urol 177(1): 365-368.
21. Donlan RM, Costerton JW (2002) Biofilm: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15: 167-193.
22. Choong S, Whitfield H (2000) Biofilms and their role in infections in urology. BJU Int 86(8): 935-941.
23. Verstraelen H, Verhelst R, Vaneechoutte M, Temmerman M (2010) The epidemiology of bacterial vaginosis in relation to sexual behaviour. BMC Infect Dis 10: 81.
24. Cai T, Mazzoli S, Meacci F, Boddi V, Mondaini N, Malossini G, Bartoletti R (2011) Epidemiological features and resistance pattern in uropathogens isolated from chronic bacterial prostatitis. J Microbiol 49(3): 448-454.
25. Bergman B, Wedren H, Holm SE (1989) Staphylococcus saprophyticus in males with symptoms of chronic prostatitis. Urology 34(5): 241-245.
26. Murphy AB, Mecejko A, Taylor A, Nadler RB (2009) Chronic prostatitis: management strategies. Drugs 69: 71-84.
27. Nickel JC, Olson ME, Barabas A, Benediktsson H, Dasgupta MK, Costerton JW (1990) Pathogenesis of chronic bacterial prostatitis in an animal model. Br J Urol 66(1): 47-54.